• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer.

作者信息

Churchill Timothy W, Smith Matthew R, Michaelson M Dror, Lee Richard J, Guseh James Sawalla, Wasfy Meagan M, Meneely Erika, Olivier Kara, Baggish Aaron L, Saylor Philip J

机构信息

Cardiovascular Performance Program, Massachusetts General Hospital, Division of Cardiology, Harvard Medical School, Boston, Massachusetts.

Massachusetts General Hospital Cancer Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts.

出版信息

J Am Soc Echocardiogr. 2024 Jul;37(7):706-708. doi: 10.1016/j.echo.2024.03.006. Epub 2024 Mar 16.

DOI:10.1016/j.echo.2024.03.006
PMID:38499230
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11227417/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19cd/11227417/f421a4ca5b7a/nihms-1977908-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19cd/11227417/f421a4ca5b7a/nihms-1977908-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/19cd/11227417/f421a4ca5b7a/nihms-1977908-f0001.jpg

相似文献

1
Cardiac Structural Changes and Declining Cardiorespiratory Fitness During Androgen Deprivation Therapy for Prostate Cancer.前列腺癌雄激素剥夺治疗期间的心脏结构变化及心肺适能下降
J Am Soc Echocardiogr. 2024 Jul;37(7):706-708. doi: 10.1016/j.echo.2024.03.006. Epub 2024 Mar 16.
2
Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.运动可改善接受雄激素剥夺治疗的前列腺癌患者的最大摄氧量和身体成分。
Med Sci Sports Exerc. 2017 Aug;49(8):1503-1510. doi: 10.1249/MSS.0000000000001277.
3
[Evaluation of a supervised six-month exercise program in patients with prostate cancer receiving androgen-deprivation therapy].[对接受雄激素剥夺治疗的前列腺癌患者进行的一项为期六个月的有监督运动计划的评估]
Rev Med Liege. 2019 Jan;74(1):36-40.
4
Prospective study of exercise intervention in prostate cancer patients on androgen deprivation therapy.前列腺癌患者接受雄激素剥夺治疗时运动干预的前瞻性研究。
J Med Imaging Radiat Oncol. 2014;58(3):369-76. doi: 10.1111/1754-9485.12115. Epub 2013 Oct 4.
5
Comparing aerobic and resistance exercise emphasis during androgen deprivation and radiation therapy for prostate cancer: A randomised feasibility trial.前列腺癌雄激素剥夺和放射治疗期间有氧运动与抗阻运动重点比较：一项随机可行性试验
Support Care Cancer. 2025 Jun 20;33(7):601. doi: 10.1007/s00520-025-09650-z.
6
Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy.雄激素剥夺治疗的肥胖前列腺癌患者的减肥治疗。
Med Sci Sports Exerc. 2021 Mar 1;53(3):470-478. doi: 10.1249/MSS.0000000000002509.
7
Prognostic value of biochemical response to neoadjuvant androgen deprivation before external beam radiotherapy for prostate cancer: A systematic review of the literature.新辅助雄激素剥夺治疗前生化反应对前列腺癌外照射放疗预后价值的系统评价。
Cancer Treat Rev. 2016 May;46:35-41. doi: 10.1016/j.ctrv.2016.03.016. Epub 2016 Apr 7.
8
Impact of androgen-deprivation therapy on physical function and quality of life in men with nonmetastatic prostate cancer.雄激素剥夺疗法对非转移性前列腺癌男性患者身体功能和生活质量的影响。
J Clin Oncol. 2010 Dec 1;28(34):5038-45. doi: 10.1200/JCO.2010.29.8091. Epub 2010 Nov 1.
9
Adding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: A systematic review and meta-analysis.在转移性激素敏感性前列腺癌男性患者中，在雄激素剥夺治疗基础上加用阿比特龙：一项系统评价和荟萃分析。
Eur J Cancer. 2017 Oct;84:88-101. doi: 10.1016/j.ejca.2017.07.003. Epub 2017 Aug 8.
10
Early Docetaxel and Androgen Deprivation in the Treatment of Metastatic, Hormone-sensitive Prostate Cancer.早期多西他赛与雄激素剥夺疗法治疗转移性激素敏感性前列腺癌
Rev Recent Clin Trials. 2016;11(4):317-323. doi: 10.2174/1574887111666160719145456.

本文引用的文献

1
Reduced Cardiorespiratory Fitness and Increased Cardiovascular Mortality After Prolonged Androgen Deprivation Therapy for Prostate Cancer.前列腺癌长期雄激素剥夺治疗后心肺适能降低与心血管死亡率增加
JACC CardioOncol. 2020 Nov 17;2(4):553-563. doi: 10.1016/j.jaccao.2020.08.011. eCollection 2020 Nov.
2
Cardiorespiratory Fitness and Mortality in Healthy Men and Women.心肺适能与健康男女的死亡率。
J Am Coll Cardiol. 2018 Nov 6;72(19):2283-2292. doi: 10.1016/j.jacc.2018.08.2166.
3
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.超声心动图成人左心室容量和射血分数测量：美国超声心动图学会和欧洲心血管影像协会的更新建议。
J Am Soc Echocardiogr. 2015 Jan;28(1):1-39.e14. doi: 10.1016/j.echo.2014.10.003.
4
Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis.定量评估雄激素剥夺疗法治疗前列腺癌后发生致命和非致命心血管疾病风险的观察性证据：一项荟萃分析。
Eur Urol. 2015 Sep;68(3):386-96. doi: 10.1016/j.eururo.2014.11.039. Epub 2014 Dec 5.
5
Metabolic complications of androgen deprivation therapy for prostate cancer.雄激素剥夺疗法治疗前列腺癌的代谢并发症。
J Urol. 2013 Jan;189(1 Suppl):S34-42; discussion S43-4. doi: 10.1016/j.juro.2012.11.017.
6
Impact of androgen deprivation therapy on cardiovascular disease and diabetes.雄激素剥夺疗法对心血管疾病和糖尿病的影响。
J Clin Oncol. 2009 Jul 20;27(21):3452-8. doi: 10.1200/JCO.2008.20.0923. Epub 2009 Jun 8.
7
Changes in bone mineral density and body composition during initial and long-term gonadotropin-releasing hormone agonist treatment for prostate carcinoma.前列腺癌患者在促性腺激素释放激素激动剂初始治疗及长期治疗期间骨矿物质密度和身体成分的变化
Cancer. 2005 Oct 15;104(8):1633-7. doi: 10.1002/cncr.21381.